HOME > ARCHIVE
ARCHIVE
- Korosho Sets Up Study Group to Expedite Approval of Medical Devices
October 30, 2006
- Korosho to Question Major Pharmacy Chains on What They Do to Promote Use of Generics
October 30, 2006
- MIC Medical Expands Medical Image Analysis Business
October 30, 2006
- HIB Urges Pharmacies to Help Promote Use of GE Drugs
October 30, 2006
- AdvaMed
October 30, 2006
- Taiyo Yakuhin Aims to Be "Most Trusted Generic Drug Company"
October 30, 2006
- MEDICAL DEVICE NEWS IN BRIEF
October 30, 2006
- 2006 Symposium of APEC Network on Pharma Regulatory Science
October 30, 2006
- TOPICS Olympus Receives Good Design Awards 2006 for 3 Products
October 30, 2006
- Japan-US Conference on Drug Review and Safety Wrapped Up
October 30, 2006
- Health Economics Forum Japan Symposium
October 30, 2006
- JPMA Expects Promotion of Innovation by Abe Cabinet: Mr Yamabe
October 30, 2006
- TOPICS AstraZeneca to Support Aging and Neglected Villages
October 30, 2006
- Korosho to Set Up Study Group to Discuss Measures to Eliminate "Drug Lag"
October 30, 2006
- Family History of Lung Cancer Doubles the Risk: Study
October 30, 2006
- Celecoxib Recommended for Approval
October 30, 2006
- Politicians' Leadership Essential to Solve Industry Problems: Dr Aoki
October 30, 2006
- 4 Domestic Companies to File for Pre-pandemic Flu Vaccine in 2007
October 30, 2006
- REGULATORY NEWS IN BRIEF
October 30, 2006
- 21st Scientific Meeting of the International Society of Hypertension (ISH2006)
October 30, 2006
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
